By Yakubu LAAH InvestAdvocate
Lagos (INVESTADVOCATE)- Healthcare firm, Neimeth International Pharmaceuticals Plc said on Thursday its 2015 third quarter (Q3) profit before tax (PBT) moved from a profit of N11.72 million in the Q3 of 2014 to a loss N56.65 million.
Similarly, profit after tax (PAT) also went from a profit of N11.72 million to a loss of N56.65 million in the review period of 2015.
Revenue of the healthcare company declined from N1.312 billion to N996.83 million in the review period of 2015; showing a decline of 24 percent, Neimeth said in a filing with the Nigerian Stock Exchange (NSE).
